Esteban Cugat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Esteban Cugat has a total of 178 co-authors. Here are the top co-authors by number of shared publications:
- Miguel Angel Gomez Bravo
Department of Surgery, Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain
5 shared publications - Eric Herrero Fonollosa
Univ Barcelona UB, Hosp Univ Mutua Terrassa, Unidad HBP, Cirugia Gen & Aparato Digest, Barcelona, Spain
4 shared publications - María Isabel García-Domingo
Department of Surgery, Hospital Universitario Mutua de Terrassa, 08221 Terrassa, Spain
4 shared publications - Aurora Rodríguez Campos
Univ Barcelona UB, Hosp Univ Mutua Terrassa, Serv Anestesiol, Barcelona, Spain
3 shared publications - Gerardo Blanco-Fernández
Department of HBP and Liver Transplant Surgery, University Hospital Complex Badajoz, University of Extremadura, Badajoz, Spain, unex.es
3 shared publications - Jordi Navinés
Department of General and Digestive Surgery, Hospital Germans Trias i Pujol , Barcelona
3 shared publications
Latest Publications
- Open Access
- 11 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 7035
Functional Status and Postoperative Outcomes After Left Pancreatectomy for Pancreatic Neuroendocrine Tumors: An Exploratory Analysis from the Prospective SPANDISPAN Study
Background: Whether tumor functional status influences postoperative outcomes after left pancreatectomy (LP) for pancreatic neuroendocrine tumors (pNETs) remains unknown. We evaluated the association between functional status, perioperative management, and postoperative outcomes in a prospective nationwide cohort of patients undergoing LP for pNET. Methods: This prespecified analysis of the prospective multicenter SPANDISPAN study included consecutive patients undergoing elective LP at 41 Spanish hospitals between February 2022 and January 2023. Of 98 patients with pNET, functional status was available in 88 (14 functioning and 74 non-functioning tumors). Perioperative characteristics, spleen preservation, and postoperative outcomes were compared according to tumor functional status. Results: Spleen preservation was performed in 28.6% of functioning and 18.9% of non-functioning tumors (p = 0.472; risk difference 9.7 percentage points, 95% CI [confidence interval] −15.6 to 34.9). Patients with functioning tumors had lower rates of clinically relevant postoperative pancreatic fistula (7.1% vs. 36.5%; p = 0.032; risk difference −29.3 percentage points, 95% CI −46.7 to −12.0), shorter length of hospital stay (median 4 vs. 7 days; p = 0.036), and no 90-day readmissions (0% vs. 31.1%; p = 0.017; risk difference −31.1 percentage points, 95% CI −41.6 to −20.5). Tumor functional status was not significantly associated with the use of spleen-preserving resection. Conclusions: Functional status is associated with clinically relevant differences in postoperative outcomes after LP for pNET. Patients with functioning tumors experienced lower postoperative morbidity than those with non-functioning tumors, whereas no statistically significant association was detected between tumor functional status and spleen preservation. These exploratory findings suggest that tumor functional status may warrant consideration as an additional factor in perioperative risk stratification and patient counseling, pending confirmation in larger, adequately powered studies; spleen preservation should continue to be guided by established oncological criteria.
- 11 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 7035
Open AccessFunctional Status and Postoperative Outcomes After Left Pancreatectomy for Pancreatic Neuroendocrine Tumors: An Exploratory Analysis from the Prospective SPANDISPAN Study
Background: Whether tumor functional status influences postoperative outcomes after left pancreatectomy (LP) for pancreatic neuroendocrine tumors (pNETs) remains unknown. We evaluated the association between functional status, perioperative management, and postoperative outcomes in a prospective nationwide cohort of patients undergoing LP for pNET. Methods: This prespecified analysis of the prospective multicenter SPANDISPAN study included consecutive patients undergoing elective LP at 41 Spanish hospitals between February 2022 and January 2023. Of 98 patients with pNET, functional status was available in 88 (14 functioning and 74 non-functioning tumors). Perioperative characteristics, spleen preservation, and postoperative outcomes were compared according to tumor functional status. Results: Spleen preservation was performed in 28.6% of functioning and 18.9% of non-functioning tumors (p = 0.472; risk difference 9.7 percentage points, 95% CI [confidence interval] −15.6 to 34.9). Patients with functioning tumors had lower rates of clinically relevant postoperative pancreatic fistula (7.1% vs. 36.5%; p = 0.032; risk difference −29.3 percentage points, 95% CI −46.7 to −12.0), shorter length of hospital stay (median 4 vs. 7 days; p = 0.036), and no 90-day readmissions (0% vs. 31.1%; p = 0.017; risk difference −31.1 percentage points, 95% CI −41.6 to −20.5). Tumor functional status was not significantly associated with the use of spleen-preserving resection. Conclusions: Functional status is associated with clinically relevant differences in postoperative outcomes after LP for pNET. Patients with functioning tumors experienced lower postoperative morbidity than those with non-functioning tumors, whereas no statistically significant association was detected between tumor functional status and spleen preservation. These exploratory findings suggest that tumor functional status may warrant consideration as an additional factor in perioperative risk stratification and patient counseling, pending confirmation in larger, adequately powered studies; spleen preservation should continue to be guided by established oncological criteria.
- Open Access
- 30 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (17) , 6144
The Trunk of Henle and Belcher’s Vein: Important Venous Landmarks in Robot-Assisted Pancreatoduodenectomy
Background: The Trunk of Henle and the posterosuperior pancreaticoduodenal vein (Belcher’s Vein) are consistent anatomical landmarks of the portomesenteric venous system. Their recognition is particularly relevant in robot-assisted pancreatoduodenectomy (RAPD), where uncinate process dissection from the portal–mesenteric axis represents the most technically demanding step. Methods: We describe a stepwise robotic surgical approach emphasizing the identification, isolation, and safe division of the Trunk of Henle and Belcher’s Vein. Intraoperative illustrations are provided to demonstrate the use of these veins as reproducible landmarks during dissection of the pancreatic head and uncinate process. Results: Incorporating these veins as key reference points facilitates precise dissection, improves vascular control, and minimizes intraoperative bleeding. Their consistent anatomical presence allows systematization of the uncinate process approach and reliable exposure of the portal–mesenteric axis. Conclusions: The Trunk of Henle and Belcher’s Vein serve as valuable venous landmarks in RAPD. Their routine identification may improve surgical safety, reduce conversion risk, and contribute to a standardized, reproducible methodology for robotic pancreatic head resection.
- 30 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (17) , 6144
Open AccessThe Trunk of Henle and Belcher’s Vein: Important Venous Landmarks in Robot-Assisted Pancreatoduodenectomy
Background: The Trunk of Henle and the posterosuperior pancreaticoduodenal vein (Belcher’s Vein) are consistent anatomical landmarks of the portomesenteric venous system. Their recognition is particularly relevant in robot-assisted pancreatoduodenectomy (RAPD), where uncinate process dissection from the portal–mesenteric axis represents the most technically demanding step. Methods: We describe a stepwise robotic surgical approach emphasizing the identification, isolation, and safe division of the Trunk of Henle and Belcher’s Vein. Intraoperative illustrations are provided to demonstrate the use of these veins as reproducible landmarks during dissection of the pancreatic head and uncinate process. Results: Incorporating these veins as key reference points facilitates precise dissection, improves vascular control, and minimizes intraoperative bleeding. Their consistent anatomical presence allows systematization of the uncinate process approach and reliable exposure of the portal–mesenteric axis. Conclusions: The Trunk of Henle and Belcher’s Vein serve as valuable venous landmarks in RAPD. Their routine identification may improve surgical safety, reduce conversion risk, and contribute to a standardized, reproducible methodology for robotic pancreatic head resection.
- Open Access
- 17 July 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 399
Pencil cleaning technique for robotic liver parenchymal transection: a step further to systematization beyond the microfracture-coagulation method
Robotic liver resections based on Laennec’s capsule pedicular driven dissection is a challenging surgical procedure, because of the intrinsic relationship between the liver parenchyma and the main intrahepatic vessels. The absence of anatomical landmarks and the frailty of the fine vascular structures requires broad experience, anatomical knowledge and refined technical skills to successfully perform such a procedure. As robotic platforms do no offer the standard laparoscopic advanced tools for liver resection, real robotic approach has been proposed as a default technique for the liver parenchymal transection, precise robotic anatomical and parenchymal-sparing liver resection, and pedicle driven dissection, like the microfracture-coagulation method. A more specific refinement of the real robotic approach, similar to the pencil cleaning process, useful in very careful deep dissections, is defined towards the standardization of the real robotic approach in advanced liver surgery. The rationale of the method, its indications and tips and tricks are described in detail.
- 17 July 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 399
Open AccessPencil cleaning technique for robotic liver parenchymal transection: a step further to systematization beyond the microfracture-coagulation method
Robotic liver resections based on Laennec’s capsule pedicular driven dissection is a challenging surgical procedure, because of the intrinsic relationship between the liver parenchyma and the main intrahepatic vessels. The absence of anatomical landmarks and the frailty of the fine vascular structures requires broad experience, anatomical knowledge and refined technical skills to successfully perform such a procedure. As robotic platforms do no offer the standard laparoscopic advanced tools for liver resection, real robotic approach has been proposed as a default technique for the liver parenchymal transection, precise robotic anatomical and parenchymal-sparing liver resection, and pedicle driven dissection, like the microfracture-coagulation method. A more specific refinement of the real robotic approach, similar to the pencil cleaning process, useful in very careful deep dissections, is defined towards the standardization of the real robotic approach in advanced liver surgery. The rationale of the method, its indications and tips and tricks are described in detail.
- Open Access
- 3 July 2025
- Published by MDPI AG in Preprints.org
The Trunk of Henle and Belcher’s Vein: Important Venous Landmarks in Robot-Assisted Pancreatoduodenectomy
The trunk of Henle (TH) and the posterosuperior pancreaticoduodenal vein, also known as Belcher’s Vein (BV), are important anatomical landmarks within the portomesenteric vascular anatomy during robot-assisted pancreatoduodenectomy. A detailed understanding of these veins is necessary for the safe and effective resection in the robotic approach for oncological surgery of the pancreatic head and uncinate process. This technical note describes in detail the stepwise approach to use these veins as reference landmarks during robot-assisted pancreatoduodenectomy. This methodology may improve the dissection precision, reduce the vascular injury risk, and enhance the oncological outcomes.
- 3 July 2025
- Published by MDPI AG in Preprints.org
Open AccessThe Trunk of Henle and Belcher’s Vein: Important Venous Landmarks in Robot-Assisted Pancreatoduodenectomy
The trunk of Henle (TH) and the posterosuperior pancreaticoduodenal vein, also known as Belcher’s Vein (BV), are important anatomical landmarks within the portomesenteric vascular anatomy during robot-assisted pancreatoduodenectomy. A detailed understanding of these veins is necessary for the safe and effective resection in the robotic approach for oncological surgery of the pancreatic head and uncinate process. This technical note describes in detail the stepwise approach to use these veins as reference landmarks during robot-assisted pancreatoduodenectomy. This methodology may improve the dissection precision, reduce the vascular injury risk, and enhance the oncological outcomes.
- Open Access
- 15 November 2024
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (12) , 7798-7805
Intraoperative liquid biopsy as a tool for detecting R1 resection during pancreatoduodenectomy in patients with pancreatic carcinoma: the CETUPANC trial (part II)
Introduction: A positive surgical margin (R1 resection) is a relevant risk factor for local recurrence in patients with pancreatic ductal adenocarcinoma of the pancreas (PDAC). An intraoperative liquid biopsy (ILB) based on tumor cell mobilization could help to detect R1 resection intraoperatively. Objective: To evaluate the potential role of the intraoperative circulating tumor cells (CTCs) and cluster mobilization on the R0/R1 detection. Methods: Sixty-three patients with resectable PDAC of the head of the pancreas were prospective enrolled under the CETUPANC trial. Open pancreaticoduodenectomy (PD) was done in all patients. Intraoperative CTCs and clusters were determined during PD. Results: The overall rate of R1 resection was 34.9% (22/63 patients). Multivariate analysis showed that factors associated with R1 resection (AUC=0.920) were the presence of undifferentiated G3 tumor (P=0.017), microscopic vascular invasion (P=0.016), and the intraoperative increase of both free CTCs and clusters in portal vein determination from the beginning to the end of the surgery (P=0.002 and P=0.005, respectively). A specific logistic regression model, including delta end to baseline CTCs and cluster mobilization to achieve a combined cut-off to detect R1 detection was calculated (AUC=0.799). The obtained R1-index based on ILB had 84% of sensitivity and 68% of specificity to detect R1 resection. Conclusions: The ILB based on the intraoperative mobilization of CTCs and clusters from the beginning to the end of the PD was a predictive factor to detect R1 resection in patients with PDAC.
- 15 November 2024
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (12) , 7798-7805
Open AccessIntraoperative liquid biopsy as a tool for detecting R1 resection during pancreatoduodenectomy in patients with pancreatic carcinoma: the CETUPANC trial (part II)
Introduction: A positive surgical margin (R1 resection) is a relevant risk factor for local recurrence in patients with pancreatic ductal adenocarcinoma of the pancreas (PDAC). An intraoperative liquid biopsy (ILB) based on tumor cell mobilization could help to detect R1 resection intraoperatively. Objective: To evaluate the potential role of the intraoperative circulating tumor cells (CTCs) and cluster mobilization on the R0/R1 detection. Methods: Sixty-three patients with resectable PDAC of the head of the pancreas were prospective enrolled under the CETUPANC trial. Open pancreaticoduodenectomy (PD) was done in all patients. Intraoperative CTCs and clusters were determined during PD. Results: The overall rate of R1 resection was 34.9% (22/63 patients). Multivariate analysis showed that factors associated with R1 resection (AUC=0.920) were the presence of undifferentiated G3 tumor (P=0.017), microscopic vascular invasion (P=0.016), and the intraoperative increase of both free CTCs and clusters in portal vein determination from the beginning to the end of the surgery (P=0.002 and P=0.005, respectively). A specific logistic regression model, including delta end to baseline CTCs and cluster mobilization to achieve a combined cut-off to detect R1 detection was calculated (AUC=0.799). The obtained R1-index based on ILB had 84% of sensitivity and 68% of specificity to detect R1 resection. Conclusions: The ILB based on the intraoperative mobilization of CTCs and clusters from the beginning to the end of the PD was a predictive factor to detect R1 resection in patients with PDAC.
- 19 September 2024
- Published by Elsevier in Cirugía Española (English Edition)
- Vol. 102 (10) , 540-547
Need for a targeted perioperative antibiotic treatment protocol for patients with preoperative biliary drainage undergoing pancreaticoduodenectomy
- 19 September 2024
- Published by Elsevier in Cirugía Española (English Edition)
- Vol. 102 (10) , 540-547
Need for a targeted perioperative antibiotic treatment protocol for patients with preoperative biliary drainage undergoing pancreaticoduodenectomy
- 19 September 2024
- Published by Elsevier in Cirugía Española
- Vol. 102 (10) , 540-547
Necesidad de un protocolo de tratamiento antibiótico perioperatorio dirigido para pacientes con drenaje biliar preoperatorio intervenidos de duodenopancreatectomía cefálica
- 19 September 2024
- Published by Elsevier in Cirugía Española
- Vol. 102 (10) , 540-547
Necesidad de un protocolo de tratamiento antibiótico perioperatorio dirigido para pacientes con drenaje biliar preoperatorio intervenidos de duodenopancreatectomía cefálica
- 11 February 2023
- Published by Elsevier in Cirugía Española (English Edition)
- Vol. 101 (7) , 463-465
Robotic HBP surgery: a real opportunity with future potential
- 11 February 2023
- Published by Elsevier in Cirugía Española (English Edition)
- Vol. 101 (7) , 463-465
Robotic HBP surgery: a real opportunity with future potential
- Open Access
Impact of Preoperative Chemotherapy Features on Patient Outcomes after Hepatectomy for Initially Unresectable Colorectal Cancer Liver Metastases: A LiverMetSurvey Analysis
Background: Prognostic factors have been extensively reported after resection of colorectal liver metastases (CLM); however, specific analyses of the impact of preoperative systemic anticancer therapy (PO-SACT) features on outcomes is lacking. Methods: For this real-world evidence study, we used prospectively collected data within the international surgical LiverMetSurvey database from all patients with initially-irresectable CLM. The main outcome was Overall Survival (OS) after surgery. Disease-free (DFS) and hepatic-specific relapse-free survival (HS-RFS) were secondary outcomes. PO-SACT features included duration (cumulative number of cycles), choice of the cytotoxic backbone (oxaliplatin- or irinotecan-based), fluoropyrimidine (infusional or oral) and addition or not of targeted monoclonal antibodies (anti-EGFR or anti-VEGF). Results: A total of 2793 patients in the database had received PO-SACT for initially irresectable diseases. Short (p = 0.046), DFS (HR: 0.81; p = 0.016) and HS-RFS (HR: 0.80; p = 0.05). All other PO-SACT features yielded basically comparable results. Conclusions: In this international cohort, provided that PO-SACT allowed conversion to resectability in initially irresectable CLM, surgery performed as soon as technically feasible resulted in the best outcomes. When resection was achieved, our findings indicate that the choice of PO-SACT regimen had a marginal if any, impact on outcomes.
Open AccessImpact of Preoperative Chemotherapy Features on Patient Outcomes after Hepatectomy for Initially Unresectable Colorectal Cancer Liver Metastases: A LiverMetSurvey Analysis
Background: Prognostic factors have been extensively reported after resection of colorectal liver metastases (CLM); however, specific analyses of the impact of preoperative systemic anticancer therapy (PO-SACT) features on outcomes is lacking. Methods: For this real-world evidence study, we used prospectively collected data within the international surgical LiverMetSurvey database from all patients with initially-irresectable CLM. The main outcome was Overall Survival (OS) after surgery. Disease-free (DFS) and hepatic-specific relapse-free survival (HS-RFS) were secondary outcomes. PO-SACT features included duration (cumulative number of cycles), choice of the cytotoxic backbone (oxaliplatin- or irinotecan-based), fluoropyrimidine (infusional or oral) and addition or not of targeted monoclonal antibodies (anti-EGFR or anti-VEGF). Results: A total of 2793 patients in the database had received PO-SACT for initially irresectable diseases. Short (p = 0.046), DFS (HR: 0.81; p = 0.016) and HS-RFS (HR: 0.80; p = 0.05). All other PO-SACT features yielded basically comparable results. Conclusions: In this international cohort, provided that PO-SACT allowed conversion to resectability in initially irresectable CLM, surgery performed as soon as technically feasible resulted in the best outcomes. When resection was achieved, our findings indicate that the choice of PO-SACT regimen had a marginal if any, impact on outcomes.
- 25 June 2022
- Published by Elsevier in Cirugía Española
- Vol. 100 (12) , 789
Hepatectomía izquierda laparoscópica con resección y reconstrucción de arteria hepática derecha por colangiocarcinoma intrahepático
- 25 June 2022
- Published by Elsevier in Cirugía Española
- Vol. 100 (12) , 789
Hepatectomía izquierda laparoscópica con resección y reconstrucción de arteria hepática derecha por colangiocarcinoma intrahepático